跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVIACT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BRIVIACT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
BRIVIACT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 17, 2022
Approval ID
35d67c96a526d072
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
35d67c96a526d072
Drug Cima Aemps Name
BRIVIACT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
151073006IP
Holder Company Name
Ucb Pharma
Marketing Company Name
Difarmed S.L.
Holder Company Detail Path
/organization/ucb-pharma-sa
Authorization Date
2022-11-17
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 17, 2022
Approval ID
35d67c96a526d072
Type
Standard
Back to CIMA-AEMPS Approvals
